NCT02787057View on ClinicalTrials.gov

Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related Peritonitis

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Peritoneal Dialysis Associated Peritonitis
Interventions
DRUG

vancomycin

IP vancomycin 1g every 5 days

DRUG

moxifloxacin

oral moxifloxacin 400mg QD

DRUG

ceftazidime

IP ceftazidime 1g QD

All Listed Sponsors
lead

Peking University First Hospital

OTHER

NCT02787057 - Vancomycin Plus Moxifloxacin Versus Vancomycin Plus Ceftazidime for the Treatment of Peritoneal Dialysis (PD)-Related Peritonitis | Biotech Hunter | Biotech Hunter